![Amol Soin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amol Soin
Chief Tech/Sci/R&D Officer at JANONE INC.
Net worth: 308 000 $ as of 30/05/2024
Amol Soin active positions
Companies | Position | Start | End |
---|---|---|---|
JANONE INC. | Chief Tech/Sci/R&D Officer | 28/01/2020 | - |
TheraVasc, Inc.
![]() TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Director/Board Member | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Ohio Pain Clinic | Chairman | - | - |
Founder | - | - | |
Chief Tech/Sci/R&D Officer | - | - | |
Soin Neuroscience, Inc.
![]() Soin Neuroscience, Inc. Medical SpecialtiesHealth Technology Soin Neuroscience, Inc. is a biotech company that specializes in non-opioid based pain management therapies. SNI is based in Dayton, OH and has recently started a medical device division, with several neuromodulation technologies in development. SNI is also working on machine learning and AI-based technologies to help augment physician decision making to make precision medicine possible. However, their sacral nerve stimulation device and spinal cord stimulation device are not approved for use in humans and are currently in early testing phases. The private company was founded by Amol Soin, MD, who has been the CEO since incorporation. | Chief Executive Officer | - | - |
Founder | - | - | |
Soin Therapeutics LLC
![]() Soin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of JanOne, Inc., Soin Therapeutics LLC is a biotechnology company based in Dayton, OH. The company has developed multiple different drugs to treat several chronic conditions, with its lead product being a novel proprietary formulation of low dose naltrexone to treat complex regional pain syndrome (CRPS). Soin Therapeutics has received an orphan drug designation from the FDA for their lead product and is planning to commence a large national late-stage efficacy trial in 2022 of their lead product in CRPS patients. The company was founded by Amol Soin, who has been the CEO since incorporation. Soin Therapeutics was acquired by JanOne, Inc. on December 28, 2022 for $30 million. | Chief Executive Officer | - | - |
Founder | - | - |
Career history of Amol Soin
Former positions of Amol Soin
Companies | Position | Start | End |
---|---|---|---|
TriState Pain Society | President | - | - |
Physician Investment Group LLC
![]() Physician Investment Group LLC Financial ConglomeratesFinance Physician Investment Group LLC provides investment services. The private company is based in Dayton, OH. The company was founded by Amol Soin. | Founder | - | - |
American Society of Interventional Pain Physicians, Inc.
![]() American Society of Interventional Pain Physicians, Inc. Miscellaneous Commercial ServicesCommercial Services American Society of Interventional Pain Physicians, Inc. is an association that provides ambulatory and pain management services. The private company is based in Paducah. | President | - | - |
Society of Interventional Pain Management Surgery Centers | President | - | - |
░░░ ░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ | ░░░░░░░░░ | - | - |
Training of Amol Soin
Brown University | Graduate Degree |
University of Akron | Undergraduate Degree |
University of Tennessee | Masters Business Admin |
Northeast Ohio Medical University | Doctorate Degree |
Statistics
International
United States | 15 |
Operational
President | 4 |
Founder | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Sectoral
Consumer Services | 5 |
Health Technology | 4 |
Industrial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
JANONE INC. | Industrial Services |
Private companies | 9 |
---|---|
TheraVasc, Inc.
![]() TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Physician Investment Group LLC
![]() Physician Investment Group LLC Financial ConglomeratesFinance Physician Investment Group LLC provides investment services. The private company is based in Dayton, OH. The company was founded by Amol Soin. | Finance |
Ohio Pain Clinic | |
American Society of Interventional Pain Physicians, Inc.
![]() American Society of Interventional Pain Physicians, Inc. Miscellaneous Commercial ServicesCommercial Services American Society of Interventional Pain Physicians, Inc. is an association that provides ambulatory and pain management services. The private company is based in Paducah. | Commercial Services |
Soin Neuroscience, Inc.
![]() Soin Neuroscience, Inc. Medical SpecialtiesHealth Technology Soin Neuroscience, Inc. is a biotech company that specializes in non-opioid based pain management therapies. SNI is based in Dayton, OH and has recently started a medical device division, with several neuromodulation technologies in development. SNI is also working on machine learning and AI-based technologies to help augment physician decision making to make precision medicine possible. However, their sacral nerve stimulation device and spinal cord stimulation device are not approved for use in humans and are currently in early testing phases. The private company was founded by Amol Soin, MD, who has been the CEO since incorporation. | Health Technology |
The Ohio Society of Interventional Pain Physicians | |
Society of Interventional Pain Management Surgery Centers | |
TriState Pain Society | |
Soin Therapeutics LLC
![]() Soin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of JanOne, Inc., Soin Therapeutics LLC is a biotechnology company based in Dayton, OH. The company has developed multiple different drugs to treat several chronic conditions, with its lead product being a novel proprietary formulation of low dose naltrexone to treat complex regional pain syndrome (CRPS). Soin Therapeutics has received an orphan drug designation from the FDA for their lead product and is planning to commence a large national late-stage efficacy trial in 2022 of their lead product in CRPS patients. The company was founded by Amol Soin, who has been the CEO since incorporation. Soin Therapeutics was acquired by JanOne, Inc. on December 28, 2022 for $30 million. | Health Technology |
- Stock Market
- Insiders
- Amol Soin
- Experience